We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| E-therapeutics Plc | ETX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 9.00 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 9.00 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 04/11/2024 08:30 by 1347 As I said at the time I sold before the de-listing, there's too much risk and not enough progress. It's another company that suddendly 'forgets' about all it's past prospects and collaborations and heads off towards new rainbows (I noted in the last update they don't even get mentioned).Plus I wasn't going to repeat the experience with Deepmatter, where small investors got wiped out post delisting. There is no real market now so it's difficult to know a fair price and sell if you want to get out. Personally I now avoid anything where Griff has a significant stake, but each to their own hey. If it works out for you then fine but I don't 'invest' in companies that shaft small shareholders to the benefit of insiders. |
Posted at 01/11/2024 08:22 by 1347 Why are these scumbags who shafted smaller private investors (with help from certain major shareholders) bothering to tell us that they've still achieved sod all after all these years. |
Posted at 12/4/2024 06:49 by 1347 Yes, good points. I'm not sure why any fund manager would say: I'll invest in a company but only if it's not listed? If you believe the company has serious prospects then what is the downside as an investor/fund manager to it being listed? Seems more to me that existing large shareholders prefer it to be unlisted as then there is less scrutiny. Makes you wonder eh?As for the NASDAQ listing, well the pre-cursor to that is usually an OTC listing, well they had that but then delisted at the end of 27 December 2023. They gave just 4 days notice over the Christmas/New Year period, so if there were many Americans interested in the company and taking a stake then they'll be hacked off I would imagine, as are the UK PIs now. As far as AI is concerned, well I can see the potential and it's a field I've worked in, but there's an awful lot of hype/rubbish being spouted about it at the moment, including by ETX I suspect. Ask yourself this, why have they only ever had a few contracts on the go paying relatively small milestone payments after all these years? Go and look at the last Business Update in January 2024 then look at what's happened since. By the way if you chose to hold then if it's anything like Deepmatter, which I suspect it will be as Griffin was behind both, then as a minority shareholder you are not going to get much, if anything, in the way of updates and so are very likely not going to realise what's going on until it's too late. I got just a few hours notice when they did the placing and consolidation at Deepmatter that wiped all but the biggest shareholders out. Personally after this behaviour I wouldn't touch anything Ali's involved in or Griffin is a large shareholder in with a bargepole, even if they discovered eternal life, but that's just my opinion, others should DYOR as they say. |
Posted at 12/4/2024 06:11 by pireric Very much agree with The Millipede/1347Nice excuse to complain that fund managers don't understand the potential risk reward in companies in this space. Most are serial destructors of shareholder value while management get paid richly. Hence they want to go to the US which seems all too happy to throw cash at ventures in the hope that one in 5/10 turns into a multibagger to justify the other failures. Or just to ride the coattails of US retail investors who are happy to pump and dump whatever the latest theme is If they really cared about investors they would have: 1) bought out the minorities or at least put a tender offer in place 2) evaluated a US listing mechanism while keeping ETX listed in the meantime Instead they are just annoying a large proportion of the retail shareholder base. Question around their fiduciary duty to force a bunch to sell at valuations which they self-believe are too low. Eric (no holding, never have) |
Posted at 11/4/2024 17:20 by takeiteasy Moving to nasdaq saved the day for SLN with a wide variety of knowledgeable biotech start up investors to choose from. MCAP much higher in total now (many shares issued) - last fund raising significantly over subscribed. CEO here used to work at SLN and watches all this and yearns for NASDAQ listing for reaching the same benefits. |
Posted at 11/4/2024 16:18 by the millipede I genuinely think his narrative is misguided. London won’t fund this kind of company - with little revenue and a lot of hope - because we have spent years doing so and not making any money.I have been investing on AIM on and off since 2008. Speculative pharma is the same as speculative oil. Risky and capital intensive. And, over the years, high risk has turned out to mean no reward. Too many con artists, failed ventures, and investors with swingeing capital losses. New York will likely discover the same soon enough IMO. |
Posted at 25/9/2023 12:42 by maccamcd Did you listen in on the investor meet presentation a few months ago?I believe it's been mainly one retail investor who's been selling bits continuously...Annoy |
Posted at 17/7/2021 12:22 by ali47fish has anybody watched tye presentation recently on proactive by the ceo which i thought very professional but very specilised area for a lay investor to understand- perhaps some posters here might have gained some insights |
Posted at 25/2/2021 20:26 by dplewis1 No he's just a wealthy investor |
Posted at 24/11/2020 18:01 by dplewis1 Yes it's a bit of a concern. There's been nothing of substance since the collaboration announcement with Galapagos and that was in June.. for a company whose tech is supposedly in such demand this is a worry as an investor. The share price has held up fairly well but come on Ali.. you know the AIM junkies need their RNS fix! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
